Clodronate and Liposome‐Encapsulated Clodronate Are Metabolized to a Toxic ATP Analog, Adenosine 5′‐(β,γ‐Dichloromethylene) Triphosphate, by Mammalian Cells In Vitro
暂无分享,去创建一个
J. Mönkkönen | G. Blackburn | J. Frith | M. Rogers | Julie C. Frith | Jukka Mönkkönen | G. Michael Blackburn | R. Graham G. Russell | Michael J. Rogers | R. Russell | J. C. Frith
[1] P. Reitsma,et al. APD in Paget's disease of bone. Role of the mononuclear phagocyte system? , 1980, Arthritis and rheumatism.
[2] A. Urtti,et al. Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro. , 1994, Journal of drug targeting.
[3] T. Martin,et al. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. , 1993, The Journal of clinical investigation.
[4] S. Miller,et al. The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat , 1979, The Anatomical record.
[5] P. Reitsma,et al. Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro. , 1982, The Journal of clinical investigation.
[6] B. Uitdehaag,et al. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages , 1990, The Journal of experimental medicine.
[7] M. Williamson,et al. Metabolism of halogenated bisphosphonates by the cellular slime mould Dictyostelium discoideum. , 1992, Biochemical and biophysical research communications.
[8] C. Bortner,et al. The role of DNA fragmentation in apoptosis. , 1995, Trends in cell biology.
[9] T. Yoneda,et al. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[10] N. Van Rooijen. Liposome-mediated elimination of macrophages. , 1992, Research in immunology.
[11] G. Klein,et al. Methylenediphosphonate, a metabolic poison in Dictyostelium discoideum. Phosphorus-31 NMR evidence for accumulation of adenosine 5'-(.beta.,.gamma.-methylenetriphosphate) and diadenosine 5',5'''-P1,P4-(P2,P3-methylenetetraphosphate) , 1988 .
[12] G. Blackburn,et al. The synthesis and metal binding characteristics of novel, isopolar phosphonate analogues of nucleotides , 1984 .
[13] H. Fleisch,et al. The effects of diphosphonates on the growth and glycolysis of connective-tissue cells in culture. , 1978, The Biochemical journal.
[14] K. Goa,et al. Clodronate , 1994, Drugs.
[15] M. Satre,et al. Cytotoxicity of dichloromethane diphosphonate and of 1-hydroxyethane-1,1-diphosphonate in the amoebae of the slime mould Dictyostelium discoideum. A 31P NMR study. , 1992, Biochemical pharmacology.
[16] J. Kanis,et al. Comparison of three intravenous regimens of clodronate in paget disease of bone , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[17] M. Williamson,et al. Incorporation of bisphosphonates into adenine nucleotides by amoebae of the cellular slime mould Dictyostelium discoideum. , 1994, The Biochemical journal.
[18] G. Rodan,et al. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. , 1991, The Journal of clinical investigation.
[19] R. Russell,et al. DIPHOSPHONATES AND PAGET'S DISEASE OF BONE , 1971 .
[20] H. Fleisch,et al. Diphosphonates Inhibit Formation of Calcium Phosphate Crystals in vitro and Pathological Calcification in vivo , 1969, Science.
[21] T. Chambers,et al. Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone. , 1989, Bone and mineral.
[22] M. Cecchini,et al. Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[23] N. Van Rooijen,et al. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. , 1994, Journal of immunological methods.
[24] A. Douglas-Jones,et al. The effect of free and liposome‐encapsulated clodronate on the hepatic mononuclear phagocyte system in the rat , 1995, Clinical and experimental immunology.
[25] P. Boonekamp,et al. Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix. , 1986, Bone and mineral.
[26] F. Emmrich,et al. Apoptotic cell death in activated monocytes following incorporation of clodronate‐liposomes , 1996, Journal of leukocyte biology.
[27] G. Blackburn,et al. Bisphosphonates are incorporated into adenine nucleotides by human aminoacyl-tRNA synthetase enzymes. , 1996, Biochemical and biophysical research communications.
[28] A. Wyllie,et al. Cell death: the significance of apoptosis. , 1980, International review of cytology.
[29] M. Rogers,et al. Mechanisms of Action of Bisphosphonates as Inhibitors of Bone Resorption , 1996 .
[30] Gowen,et al. Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. , 1989, The Journal of clinical investigation.
[31] K. Savolainen,et al. Different effects of three bisphosphonates on nitric oxide production by RAW 264 macrophage-like cells in vitro. , 1996, The Journal of pharmacology and experimental therapeutics.
[32] C. Löwik,et al. Interleukin‐6 and the acute phase response during treatment of patients with paget's disease with the nitrogen‐containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[33] A. D. Geddes. Bisphosphonates : Structure-Activity Relationships and Therapeutic Implications , 1994 .
[34] R. Dodds,et al. Microcytophotometric analysis of human osteoclast metabolism: lack of activity in certain oxidative pathways indicates inability to sustain biosynthesis during resorption. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[35] H. Fleisch,et al. Diphosphonates Inhibit Hydroxyapatite Dissolution in vitro and Bone Resorption in Tissue Culture and in vivo , 1969, Science.
[36] G. Rodan,et al. Bisphosphonates: mechanisms of action , 1998, Endocrine reviews.
[37] F. Emmrich,et al. Treatment of rat arthritides with clodronate-containing liposomes. , 1995, Scandinavian journal of rheumatology. Supplement.
[38] F. Emmrich,et al. Long-term amelioration of rat adjuvant arthritis following systemic elimination of macrophages by clodronate-containing liposomes. , 1995, Arthritis and rheumatism.
[39] P. Schlesinger,et al. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. , 1990, The Journal of clinical investigation.
[40] D. Thiebaud,et al. Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy. , 1996, Bone.
[41] J. Kanis,et al. Consequences of neoplasia induced bone-resorption and the use of clodronate (review). , 1994, International journal of oncology.
[42] J. Lawry,et al. Bisphosphonates induce apoptosis in mouse macrophage‐like cells in vitro by a nitric oxide‐independent mechanism , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[43] F. H. Ebetino,et al. Cellular uptake of bisphosphonates: Localisation using fluorescently- labelled alendronate , 1995 .
[44] H. Fleisch. Bisphosphonates , 2012, Drugs.
[45] N. Kugai,et al. Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures. , 1996, Bone.